Delivery Order SPE2DB25D3002-SPE2DB26FLPHW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $4,119.68. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of October 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations based in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,793.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 17, 2025, and performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award...
- The Defense Logistics Agency awarded a delivery order valued at $5,514.22 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 5, 2025, with completion scheduled for August 6, 2025. This competitive award, issued on a firm fixed-price basis with no set-aside designation, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,097.65 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 2.5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $38,539.12. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a contract value of $25,340.32. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents performance at the vendor's Conshohocken, Pennsylvania location. The award utilized no set-aside designation, indicating it was competitively awarded through open procurement channels. This...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical will be supplied from the contractor's facility in...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB26FLPHWDelivery Order
The Defense Logistics Agency awarded a $2,122.38 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. This delivery order is executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs. AmerisourceBergen's contract portfolio demonstrates the company's significant role as a critical pharmaceutical distributor for federal medical procurement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with both brand-name and generic pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/23/25 |